Filter Results:
(5,098)
Show Results For
- All HBS Web
(5,098)
- People (2)
- News (906)
- Research (3,727)
- Events (40)
- Multimedia (44)
- Faculty Publications (2,622)
Show Results For
- All HBS Web
(5,098)
- People (2)
- News (906)
- Research (3,727)
- Events (40)
- Multimedia (44)
- Faculty Publications (2,622)
- 02 Jul 2020
- Working Paper Summaries
Inflation with COVID Consumption Baskets
Keywords: by Alberto Cavallo
- 31 Jul 2012
- News
What's the long-term impact of the EU's carbon market crisis?
- 12 Sep 2007
- Op-Ed
Building Sandcastles: The Subprime Adventure
inflation, a stake in the community. As home prices rose, millions of renters, particularly those with less-than-stellar credit, yearned to seize the American dream. But traditional banks shunned "credit-impaired" borrowers.... View Details
- September 13, 2023
- Article
How the Best Chief Data Officers Create Value
By: Suraj Srinivasan and Robin Seibert
Despite the rapidly increasing prominence of data and analytics functions, the majority of chief data officers (CDOs) fail to value and price the business outcomes created by their data and analytics capabilities. It comes as no surprise then that many CDOs fall behind... View Details
Srinivasan, Suraj, and Robin Seibert. "How the Best Chief Data Officers Create Value." Harvard Business Review (website) (September 13, 2023).
- May 2014 (Revised June 2016)
- Supplement
Mylan Lab's Proposed Merger with King Pharmaceuticals—courseware
By: Lucy White
Perry Capital owns shares in King and, to facilitate approval of the merger, buys shares in Mylan, whilst hedging out its economic exposure to Mylan's share price using derivatives. The price at which Mylan proposes to merge with King is generous to King shareholders,... View Details
- February 2014 (Revised June 2016)
- Case
Mylan Laboratories' Proposed Merger with King Pharmaceutical
By: Lucy White and Matt Kozlowski
Perry Capital owns shares in King and, to facilitate approval of the merger, buys shares in Mylan, whilst hedging out its economic exposure to Mylan's share price using derivatives. The price at which Mylan proposes to merge with King is generous to King shareholders,... View Details
Keywords: Mergers and Acquisitions; Voting; Ethics; Stock Shares; Investment; Lawsuits and Litigation; Ownership Stake
White, Lucy, and Matt Kozlowski. "Mylan Laboratories' Proposed Merger with King Pharmaceutical." Harvard Business School Case 214-078, February 2014. (Revised June 2016.)
- June 2000
- Article
On the Regulatory Application of Efficiency Measures
The last decade has witnessed a change to more powerful incentive schemes and the adoption by a large number of regulators of some form of price cap regimes. The efficiency frontiers literature tackles the problem of measuring the X factor in a price cap regime... View Details
Ruzzier, Christian Alejandro. "On the Regulatory Application of Efficiency Measures." Utilities Policy 9, no. 2 (June 2000): 81–92. (with M. Rossi.)
The U.S. Needs an SEC for Its Health Care System
The U.S. health care system suffers from a lack of transparency. Employers, insurers and individual consumers pay varying prices for treatments, drugs and digital information... View Details
- July 1989
- Case
NWA, Inc. - Northwest Airlines Revenue Management
Northwest Airlines is evaluating improvements to its revenue management system. This system executes a program of economic price discrimination under which the airline attempts to control the conditions on its discount fare offerings. Students must evaluate the effect... View Details
Keywords: Asset Management; Air Transportation; Management Systems; Corporate Finance; Air Transportation Industry; United States
Tiemann, Jonathan. "NWA, Inc. - Northwest Airlines Revenue Management." Harvard Business School Case 290-007, July 1989.
- February 2014
- Teaching Note
Mylan Lab's Proposed Merger with King Pharmaceuticals
By: Lucy White
Perry Capital owns shares in King and, to facilitate approval of the merger, buys shares in Mylan, whilst hedging out its economic exposure to Mylan's share price using derivatives. The price at which Mylan proposes to merge with King is generous to King shareholders,... View Details
- January 2009 (Revised February 2014)
- Case
Mylan Lab's Proposed Merger with King Pharmaceutical (Abridged)
By: Lucy White
Perry Capital owns shares in King and, to facilitate approval of the merger, buys shares in Mylan, whilst hedging out its economic exposure to Mylan's share price using derivatives. The price at which Mylan proposes to merge with King is generous to King shareholders,... View Details
Keywords: Mergers and Acquisitions; Voting; Ethics; Stock Shares; Investment; Lawsuits and Litigation; Ownership Stake
White, Lucy. "Mylan Lab's Proposed Merger with King Pharmaceutical (Abridged)." Harvard Business School Case 209-097, January 2009. (Revised February 2014.)
- 08 Jul 2009
- News
Professor Emeritus Jesse W. Markham Dead at 93
- 14 Oct 2020
- Blog Post
Veteran Financial Aid Outlook
charged. Now the good news: After going through the full-time MBA program at HBS (even with the Coronavirus disruption and finishing my last quarter on-line), I don’t think I could put a price on the education and experiences I received.... View Details
- 23 Feb 2016
- First Look
February 23, 2016
sense of pride and ownership in working with BRF, will be critical to enabling BRF's global ambitions. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/516058-PDF-ENG Harvard Business School Case 116-031 Alibaba Goes Public (B) Update on Alibaba Group's... View Details
Keywords: Sean Silverthorne
- September 2012 (Revised September 2016)
- Background Note
Convertible Notes in Seed Financings
By: Ramana Nanda, William R. Kerr and Robert F. White
This note introduces convertible notes in angel financing. It begins by delineating the differences between a priced and non-priced round. It then describes a specific example of a convertible note, with attention paid to technical details regarding valuation caps. View Details
Nanda, Ramana, William R. Kerr, and Robert F. White. "Convertible Notes in Seed Financings." Harvard Business School Background Note 813-017, September 2012. (Revised September 2016.)
- 23 Aug 2010
- News
Cranberry Industry Hits A Sour Spot
- 17 Jun 2011
- News
Wells Fargo to stop offering reverse mortgages
- March 2004 (Revised April 2005)
- Case
Midwest Office Products
By: Robert S. Kaplan
Presents an easy introduction to time-driven activity-based costing (ABC) that allows students to build a simple ABC model of order profitability. Midwest's time-driven ABC approach is based on two categories of parameter estimates. The first is the cost per hour of... View Details
Keywords: Cost; Price; Activity Based Costing and Management; Time Management; Financial Reporting; Profit; Performance Improvement; Order Taking and Fulfillment; Performance Evaluation
Kaplan, Robert S. "Midwest Office Products." Harvard Business School Case 104-073, March 2004. (Revised April 2005.)
- 2020
- Working Paper
Aggregate Advertising Expenditure in the U.S. Economy: What's Up? Is It Real?
By: Alvin J. Silk and Ernst R. Berndt
The two components of the advertising industry—the creative sector that develops and produces messages, and the communications sector that transmits messages via various media—have each been greatly affected by advances in creative design and communications... View Details
Silk, Alvin J., and Ernst R. Berndt. "Aggregate Advertising Expenditure in the U.S. Economy: What's Up? Is It Real?" NBER Working Paper Series, No. 28161, December 2020.
- 2019
- Chapter
Behavioral Economics and Health-Care Markets
By: Amitabh Chandra, Benjamin Handel and Joshua Schwartzstein
This chapter summarizes research in behavioral health economics, focusing on insurance markets and product markets in health care. We argue that the prevalence of choice difficulties and biases leading to mistakes in these markets establish a special place for them in... View Details
Keywords: Behavioral Economics; Consumer Behavior; Economics; Health Care and Treatment; Insurance; Markets
Chandra, Amitabh, Benjamin Handel, and Joshua Schwartzstein. "Behavioral Economics and Health-Care Markets." Chap. 6 in Handbook of Behavioral Economics: Foundations and Applications 2, edited by B. Douglas Bernheim, Stefano DellaVigna, and David Laibson, 459–502. Amsterdam: Elsevier/North-Holland, 2019.